News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cancer Trial Patients Take Rosy View of Likely Benefit, Oregon Health & Science University (OHSU) Study


1/28/2011 6:51:21 AM

MedPageToday -- Patients in early-trials of novel cancer treatments overestimate the likelihood that they personally will benefit from the treatment, for reasons that additional pretrial education may not overcome, researchers said. From 26% to 63% of patients in phase I or II cancer therapy trials believed they would fare better than other participants, depending on the specific outcome, according to Lynn A. Jansen, PhD, of Oregon Health and Science University in Portland, and colleagues.

Read at MedPageToday
Read at MSN
Read at Los Angeles Times


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES